Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2014 / Articles / Sep / CPhI in Numbers
Discovery & Development Ingredients

CPhI in Numbers

In October, CPhI Worldwide 2014, along with ICSE, P-MEC and InnoPack, comes to the City of Light - Paris. Here, we bring you some key facts and figures about the event.

By Charlotte Barker 09/19/2014 1 min read

Share

CPHI-Europe-160x690-Register-v4

CPhI focuses on ingredients, including APIs, excipients, custom manufacturing and finished formulation, while co-located events ICSE, P-MEC and Innopack cover contract services, equipment and packaging. Bringing together pharmaceutical companies and suppliers, the exhibition covers 60,000 m2 (so comfortable shoes are a must). Amidst all that networking, don’t miss the Pre-Connect Congress on October 6th, with talks from Alan Sheppard (IMS Health), Trevor Jones (Allergan, USA) and Sudhanshu Pandey from the Indian Ministry of Commerce and Industry.

0114-203-fig.5
0114-203-fig.1
0114-203-fig.2
0114-203-fig.3
0114-203-fig.4

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

More Articles by Charlotte Barker

False

Advertisement

Recommended

False

Related Content

The Long Road to EXCiPACT
Ingredients
The Long Road to EXCiPACT

November 7, 2014

0 min read

If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started? A good question! But, actually, I have no regrets; the story of EXCiPACT and its impact, even today, on the pharmaceutical industry makes every second worthwhile...

SORS and the Power of Light in Pharma
Ingredients Analytical Science Technology and Equipment
SORS and the Power of Light in Pharma

January 17, 2025

7 min read

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more

A DNA-Based Method of Anticounterfeiting
Dosage Forms Drug Delivery Formulation Ingredients
A DNA-Based Method of Anticounterfeiting

December 9, 2024

1 min read

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products

Who Are the Best Pharma Companies of 2025?
Business Practice Bioprocessing - Upstream & Downstream Contract Development Services Contract Manufacturing Services Small Molecules Ingredients
Who Are the Best Pharma Companies of 2025?

November 6, 2024

1 min read

Which companies in the pharma industry are the best? Categories in The Medicine Maker’s Company of the Year Awards include big pharma, CDMOs, equipment suppliers, and more – and we’re looking for your votes!

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.